ALLR

Allarity Therapeutics, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$0.88

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %227.4 / %30

Non-compliant assets / Total market cap %0 / %30

Non-compliant revenue / Total income %93.8 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology.

Website

Analysis (Turkish): ALLR Hissesi Caiz mi, Helal mi? Allarity Therapeutics, Inc. Katılım Analizi